Fotios Sampsonas

749 total citations
54 papers, 393 citations indexed

About

Fotios Sampsonas is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Fotios Sampsonas has authored 54 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 13 papers in Physiology and 7 papers in Infectious Diseases. Recurrent topics in Fotios Sampsonas's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), COVID-19 Clinical Research Studies (5 papers) and Obstructive Sleep Apnea Research (5 papers). Fotios Sampsonas is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), COVID-19 Clinical Research Studies (5 papers) and Obstructive Sleep Apnea Research (5 papers). Fotios Sampsonas collaborates with scholars based in Greece, United States and Cyprus. Fotios Sampsonas's co-authors include Kostas Spiropoulos, Kyriakos Karkoulias, Kiriakos Karkoulias, Dimosthenis Lykouras, Τheodoros Karampitsakos, Ουρανία Παπαϊωάννου, Loukas Kakoullis, Panagis Drakatos, Argyrios Tzouvelekis and Maria Lagadinou and has published in prestigious journals such as Scientific Reports, Clinical Microbiology and Infection and Current Medicinal Chemistry.

In The Last Decade

Fotios Sampsonas

46 papers receiving 380 citations

Peers

Fotios Sampsonas
S. Gautam United States
Brent E. Richardson United States
Sheryl Mitchell United States
E Grella Italy
Turhan Ece Türkiye
Fotios Sampsonas
Citations per year, relative to Fotios Sampsonas Fotios Sampsonas (= 1×) peers Andreas Pfleger

Countries citing papers authored by Fotios Sampsonas

Since Specialization
Citations

This map shows the geographic impact of Fotios Sampsonas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fotios Sampsonas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fotios Sampsonas more than expected).

Fields of papers citing papers by Fotios Sampsonas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fotios Sampsonas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fotios Sampsonas. The network helps show where Fotios Sampsonas may publish in the future.

Co-authorship network of co-authors of Fotios Sampsonas

This figure shows the co-authorship network connecting the top 25 collaborators of Fotios Sampsonas. A scholar is included among the top collaborators of Fotios Sampsonas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fotios Sampsonas. Fotios Sampsonas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Παπαϊωάννου, Ουρανία, Oraianthi Fiste, Fotios Sampsonas, et al.. (2025). The Prognostic Role of Different Blood Cell Count-to-Lymphocyte Ratios in Patients with Lung Cancer at Diagnosis. Cancers. 17(23). 3879–3879.
3.
Sampsonas, Fotios, Ουρανία Παπαϊωάννου, Vassiliki Tzelepi, et al.. (2025). Geographical Inequalities and Comorbidities in the Timely Diagnosis of NSCLC: A Real-Life Retrospective Study from a Tertiary Hospital in Western Greece. Cancers. 17(16). 2701–2701. 1 indexed citations
5.
6.
Dimitrakopoulos, Foteinos‐Ioannis, et al.. (2024). Expression of Pluripotency Factors OCT4 and LIN28 Correlates with Survival Outcome in Lung Adenocarcinoma. Medicina. 60(6). 870–870.
7.
Παπαϊωάννου, Ουρανία, et al.. (2024). Biologic agents in idiopathic hypereosinophilic syndrome: a 4-year-follow up in a case series. PA1772–PA1772.
8.
Kakoullis, Loukas, Preeti Mehrotra, George Panos, et al.. (2023). Bronchoscopy-related outbreaks and pseudo-outbreaks: A systematic review. Infection Control and Hospital Epidemiology. 45(4). 509–519. 2 indexed citations
9.
Karampitsakos, Τheodoros, Ουρανία Παπαϊωάννου, Andreas P. Kalogeropoulos, et al.. (2022). Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial. Clinical Microbiology and Infection. 29(3). 372–378. 26 indexed citations
10.
Sampsonas, Fotios, Vasileios Karamouzos, Τheodoros Karampitsakos, et al.. (2022). High-Flow vs. Low-Flow Nasal Cannula in Reducing Hypoxemic Events During Bronchoscopic Procedures: A Systematic Review and Meta-Analysis. Frontiers in Medicine. 9. 815799–815799. 10 indexed citations
11.
Παπαϊωάννου, Ουρανία, Τheodoros Karampitsakos, Fotios Sampsonas, & Argyrios Tzouvelekis. (2022). Fanconi syndrome-associated interstitial lung disease. BMJ Case Reports. 15(7). e249242–e249242. 1 indexed citations
12.
Karampitsakos, Τheodoros, Ουρανία Παπαϊωάννου, Ioannis Tomos, et al.. (2022). Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis. ERJ Open Research. 8(2). 82–2022. 1 indexed citations
13.
Sampsonas, Fotios, Ουρανία Παπαϊωάννου, Τheodoros Karampitsakos, et al.. (2021). Platypnea orthodeoxia syndrome in a patient with patent foramen ovale and normal atrial pressure. Case report and presentation of underlying pathophysiological mechanisms. Monaldi Archives for Chest Disease. 92(1).
14.
Papaefthymiou, Apostolis, Michael Doulberis, Georgia Deretzi, et al.. (2021). Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease. Minerva Endocrinology. 48(3). 346–359. 6 indexed citations
15.
Karampitsakos, Τheodoros, et al.. (2021). Interstitial Lung Diseases and the Impact of Gender. Clinics in Chest Medicine. 42(3). 531–541. 5 indexed citations
16.
Kakoullis, Loukas, Fotios Sampsonas, Vasileios Karamouzos, et al.. (2021). The impact of osteoporosis and vertebral compression fractures on mortality and association with pulmonary function in COPD: A meta-analysis. Joint Bone Spine. 89(1). 105249–105249. 13 indexed citations
17.
Karampitsakos, Τheodoros, Christina Kalogeropoulou, Vasilios Tzilas, et al.. (2021). Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model. Respiration. 101(3). 262–271. 9 indexed citations
18.
Dimitrakopoulos, Foteinos‐Ioannis, et al.. (2020). H3K4 Methylation Status and Lysine Specific Methyltransferase KMT2C Expression Correlate with Prognosis in Lung Adenocarcinoma. Current Molecular Pharmacology. 14(6). 1028–1036. 6 indexed citations
19.
Sampsonas, Fotios, Dimosthenis Lykouras, Panagis Drakatos, et al.. (2015). Association of ET-1 gene polymorphisms with COPD phenotypes in a Caucasian population. Monaldi Archives for Chest Disease. 75(2). 126–31. 1 indexed citations
20.
Georgiadou, S. P., et al.. (2012). Open-lung biopsy in patients with undiagnosed lung lesions referred at a tertiary cancer center is safe and reveals noncancerous, noninfectious entities as the most common diagnoses. European Journal of Clinical Microbiology & Infectious Diseases. 32(1). 101–105. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026